Citation:Pectasides D, Karavasilis V, Papaxoinis G, Gourgioti G, Makatsoris T, Raptou G, et al 2015

From Cancer Guidelines Wiki

Citation


Pectasides D, Karavasilis V, Papaxoinis G, Gourgioti G, Makatsoris T, Raptou G, et al. Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer. BMC Cancer 2015 May 10;15:384 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25956750.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Optimal molecular profilingBen Lee-Batescompleted
Optimal molecular profilingVictoria Freemancompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Optimal molecular profiling